Navigation Links
Patients Say Costs Determining Factor in Their Treatment Decisions
Date:6/10/2009

WASHINGTON, June 10 /PRNewswire-USNewswire/ -- Seventy-three percent of insured patients receiving assistance from Patient Access Network (PAN) Foundation reported that health care costs are influencing their medication and treatment decisions more this year than last. Nearly half of these said that cost is having a "very big" or "big" impact on whether they seek treatment or fill prescriptions.

The results were part of a 2009 patient survey to determine the effects of the economy, the impact of PAN assistance on patients' lives and their satisfaction with PAN services. PAN helps insured individuals make copayments for medications for 21 specific diseases, including certain cancers and a number of chronic illnesses.

"Our patients do have health insurance; many have Medicare, and yet they still can't meet all the out-of-pocket costs required for life-sustaining medications," said Lyn Boocock-Taylor, chair of the PAN Board of Directors. "The needs of our patients and of the estimated 25 million underinsured people nationwide simply must be considered in the current health care reform debate."

For a number of patients struggling to meet medical costs, timely PAN help sometimes means the difference between life and death, as a cutaneous T-cell lymphoma patient from Colorado wrote: "I was dying because I did not have the means to fight my cancer...thanks, thanks, thanks."

For others, like a rheumatoid arthritis patient from Texas, PAN's assistance eliminated their need to make tough financial choices, saying that: "[With PAN help] I do not have to choose my treatment over other bills that need to be paid."

Patients receiving PAN assistance also reported a striking 28 percent increase (from 71 to 99 percent) in their ability to comply with physicians' medication orders, because of their copayment assistance for vital medications and infusions. Failure to take prescriptions as prescribed often disrupts the medication's helpful effects and can lead to negative consequences such as hospitalization.

Patients said that the copayment assistance reduced family financial and emotional strain, improved their overall health and ability to take medications as prescribed and sometimes sufficiently improved their health allowing their return to work or education.

"We know patients are struggling, but these survey results confirm that we are truly reaching those who need help and making a difference in their lives," said Julie Reynes, President of PAN.

Additionally, PAN enjoys a patient satisfaction rate of 97%. Patients say that PAN's professional case managers staffing the call center are compassionate and helpful.

A summary and more information are on the PAN Web site: www.patientaccessnetwork.org and a webcast featuring the survey is available at: https://patientaccessnetwork.webex.com/patientaccessnetwork/lsr.php?AT=pb&SP=EC&rID=1341952&rKey=59830011FFBA7F58.

PAN is a nonprofit foundation dedicated to providing copayment assistance to insured patients who otherwise lack the means to meet out-of-pocket medication costs for specific diseases. Since 2004, PAN has helped more than 60,000 patients across the United States and U.S. territories. It can be reached through the Web or toll-free at 866-316-7263, with Spanish available.


'/>"/>
SOURCE Patient Access Network Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia
2. TUG Procedure by Texas Health Dallas Cardiologist Offers Hope to Millions of Patients
3. Physiological response may explain why some severely obese patients overeat
4. Kidney Community Launches Health Care Campaign to Improve Survival Rates of First-Year Dialysis Patients in Iowa
5. In Some Insomnia Patients, Brain Just Wont Shut Down
6. Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack
7. PDX-Rx.com Works With Microsoft HealthVault to Make Prescription Data Available to Patients
8. Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients
9. Anesthesia Can Make Patients Vomit After Cosmetic Surgery - World's Top Expert Says PK Anesthesia Is Better
10. Kidney Community Launches Health Care Campaign to Improve Survival Rates of First-Year Dialysis Patients in Washington, D.C.
11. VIVUS Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... Anyone with a remote control has seen the never-ending twists on ... the flipper will get rich in no time. But what about the buyers of ... for the buyer of a flipped house. An email recently sent to Gary Case ...
(Date:6/28/2017)... , ... June 28, 2017 , ... David B. Sosin, a founding partner ... took over the post of 2nd Vice President for the Illinois State Bar Association ... as the ISBA’s 3rd Vice President in 2016 following a state-wide election and served in ...
(Date:6/28/2017)... ... June 28, 2017 , ... American Farmer proudly announces ... of the award winning television series, scheduled to broadcast fourth quarter 2017. American Farmer ... as a regional supplier of garden pea seed. As demand grew, the small company ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... ZEON) is pleased to announce that a two year study conducted by the ... Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. As a part ...
(Date:6/28/2017)... ... June 28, 2017 , ... Doner Financial, a Cincinnati ... to insurance assistance and financial planning services, is announcing the commencement of a ... the region facing financial crisis. , Matthew 25: Ministries (M25M) is an international ...
Breaking Medicine News(10 mins):
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
(Date:6/8/2017)... Fla. , June 8, 2017  Less than ... that hit more than 200,000 companies, including hospital networks, ... being heralded as one of the largest online extortion ... in the healthcare market, it is imperative that providers ... protect their data from this — and many other ...
(Date:6/7/2017)... Inc., (Nasdaq: NVAX ) today announced that data ... RSV F protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) ... the journal Vaccine (the data contained ... The Company previously announced top line results from ... F Vaccine with the goal of protecting infants from RSV ...
Breaking Medicine Technology: